Stayble Therapeutics
Treating low back pain
- CEO: Andreas Gerward
- First investment year: 2016
- Fund: Västsverige
- Business sector: Life Science

Stayble Therapeutics develops an injectable treatment against chronic low back pain triggered by disc degeneration. The treatment is presumed to last the patient’s entire life and require minimal rehabilitation.